Drugs / Oral dexamethasone
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02234466 Comparator | Aug 2014 → Mar 2015 | breast cancer | University of Manitoba | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oral dexamethasone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02234466 ↗ |
| Route | Oral | “Oral dexamethasone- two 4mg tabs and one 2mg tab contained within a gelatin capsule Administered a single time, 2 hours pre-induction” NCT02234466 ↗ |